Search results
Oct 24, 2018 · Statement objectives are to: 1) Summarize the current clinical evidence regarding ADHD, 2) Establish a standard for ADHD care, and. 3) Assist Canadian clinicians in making well-informed, evidence-based decisions to enhance care of children and youth with this condition. Specific topics reviewed in Part 1, which focuses on diagnosis, include ...
- Table - PMC - National Center for Biotechnology Information
(Assessment of developmental milestones is particularly...
- ADHD: Current Concepts and Treatments in Children and ...
ADHD increases the risk of substance misuse disorders...
- The management of ADHD in children and adolescents: bringing ...
ADHD is the most common neurodevelopmental disorder...
- Table - PMC - National Center for Biotechnology Information
Feb 17, 2023 · A robust body of evidence suggests that children with ADHD are at increased risk for other co-occurring conditions, including depression, anxiety, and substance use disorders (Asherson et al., 2016; Costa Dias et al., 2013).
People also ask
What are the symptoms of ADHD in children?
How does ADHD affect childhood and adolescence?
Is there evidence for treatment of ADHD in children and adolescents?
Mar 25, 2024 · Modafinil (US Food and Drug Administration [FDA]-approved to treat narcolepsy and sleep apnea but not ADHD) in each individual study significantly improved ADHD symptoms, but aggregated estimates were nonsignificant (SMD, −0.76; CI, −1.75 to 0.23; studies = 4; n = 667) (Fig 2, Supplemental Table 1) because of high heterogeneity (I 2 = 91%).
Feb 27, 2014 · ADHD is the most prevalent neurodevelopmental disorder among children. In the United States, approximately 5.4 million children between 6 and 17 years of age (9.5% of all U.S. children) have ...
Oct 24, 2018 · The DSM does not provide for developmental level differences, which may lead to overdiagnosis of ADHD in young preschool-aged children. 2. Symptoms are associated with impairment in academic achievement, peer and family relations and adaptive skills.